Potassium

Potassium is available in multiple forms and formulations, each with specific approved uses:

• Potassium chloride oral tablets, capsules, liquids, and powders (including POKONZA): treat and prevent hypokalemia (low blood potassium) with or without metabolic alkalosis, when dietary changes or diuretic dose reduction are not enough
• Potassium chloride extended-release oral tablets and capsules: reserved for patients who cannot tolerate or comply with liquid or effervescent potassium — used to treat hypokalemia in digitalis intoxication, hypokalemic familial periodic paralysis, and to prevent hypokalemia in high-risk patients (such as those with significant cardiac arrhythmias, liver disease with ascites, or potassium-losing kidney conditions)
• Potassium chloride intravenous injection: treats potassium deficiency when oral replacement is not possible; specifically intended for fluid-restricted patients who need potassium supplementation without large fluid volumes
• Potassium citrate extended-release tablets (including Urocit-K): manage renal tubular acidosis (RTA) with calcium kidney stones; hypocitraturic calcium oxalate nephrolithiasis (calcium oxalate stones caused by low urinary citrate); and uric acid kidney stones with or without calcium stones

Potassium chloride works by directly replenishing potassium, an essential mineral the body needs for normal nerve signaling, muscle contractions (including the heart), and fluid balance. When blood potassium drops too low, muscles and the heart can malfunction — replacing it restores normal function.

Potassium citrate works differently. When absorbed, the citrate portion is metabolized into an alkaline compound that raises the pH of urine and increases urinary citrate levels. Citrate binds to calcium in the urine, reducing the amount of free calcium available to form stones. It also makes uric acid more soluble so it won't crystallize. Together, these changes make the urine less likely to produce kidney stones.

How you take potassium depends entirely on which product and form is prescribed. General principles:

• Oral liquids and powders: always dilute in water or another liquid before drinking — never take undiluted
• Extended-release tablets and capsules: take with meals and a full glass of water; swallow whole unless your label says otherwise
• Potassium citrate tablets: typically taken multiple times per day with meals or within 30 minutes of eating
• IV potassium chloride: given only in a clinical setting through a slow, controlled infusion — never as a rapid injection

Your prescriber will monitor your blood potassium levels and adjust your dose. Do not change your dose on your own, and follow your prescription label exactly.

The most common side effects involve the stomach and gut:

• Nausea or vomiting
• Stomach pain or discomfort
• Gastrointestinal irritation
• With IV use: pain, burning, redness, swelling, or inflammation at the infusion site
• Chest pain (IV use)
• Rash or allergic reaction (including swelling)

Serious reactions — including dangerous heart rhythms, cardiac arrest, severe GI bleeding, tissue damage from IV leakage, and low sodium levels — require immediate medical attention and are most likely in high-risk patients or with IV use.

• Hyperkalemia (too much potassium in the blood) is the most dangerous risk. It can cause life-threatening heart arrhythmias and cardiac arrest — sometimes with no warning symptoms. People with kidney disease, heart failure, adrenal insufficiency, or those on potassium-sparing medications are at highest risk. Regular blood tests and heart monitoring are essential.
• GI lesions: extended-release solid forms (tablets and capsules) can cause ulcers and bleeding in the stomach or intestines. Stop the medication and seek care immediately if you have severe stomach pain, vomiting, or signs of bleeding.
• IV-specific risks: too-rapid infusion can cause fatal arrhythmias. If IV solution leaks outside the vein (extravasation), it can cause serious tissue, nerve, and vascular damage — sometimes requiring surgery or amputation. Concentrated potassium IV must only be given through a central line with continuous heart monitoring.
• Hyponatremia (low sodium): IV potassium chloride can cause low blood sodium, which can lead to brain swelling, seizures, and serious neurological harm, especially in children, elderly patients, and postoperative patients.

Several medications can dangerously raise potassium levels or worsen side effects when combined with potassium products:

• Potassium-sparing diuretics (triamterene, spironolactone, amiloride): avoid combining — can cause severe, life-threatening hyperkalemia
• ACE inhibitors and ARBs (common for blood pressure and heart failure): reduce potassium excretion; monitor blood levels closely
• NSAIDs (ibuprofen, naproxen, etc.): can reduce kidney clearance of potassium; monitor carefully
• Anticholinergic medications (used for bladder, GI, or other conditions): slow gut transit and can worsen GI irritation from solid potassium forms
• Digitalis (digoxin): rapid changes in potassium levels — either too high or too low — can trigger digitalis toxicity; extra caution and monitoring required

This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.

• Tell your prescriber if you have kidney disease or poor kidney function — potassium builds up and can reach dangerous levels
• Do not use potassium citrate tablets if you have hyperkalemia or conditions that raise potassium (chronic kidney failure, uncontrolled diabetes, adrenal insufficiency, severe dehydration, or are taking potassium-sparing drugs)
• Do not use potassium citrate tablets if you have peptic ulcer disease, an active urinary tract infection, or anything that slows movement through the gut (intestinal obstruction, esophageal compression, delayed stomach emptying, or use of anticholinergic drugs)
• Use with extreme caution if you have heart failure or severe heart muscle damage
• Pregnant women: potassium citrate should only be used if clearly needed — effects on the fetus are unknown
• Breastfeeding women: use potassium citrate only if clearly needed
• Children: safety and effectiveness of potassium citrate have not been established in pediatric patients
• Tell your doctor about all medications you take, especially diuretics, blood pressure drugs, and anti-inflammatory painkillers

Too much potassium causes hyperkalemia, which can be life-threatening. Symptoms may include muscle weakness, paralysis, numbness or tingling, nausea, vomiting, low blood pressure, and dangerous heart rhythm disturbances — including cardiac arrest. Mild hyperkalemia is often symptomless and only detected on blood tests or an EKG. Any suspected potassium overdose or EKG changes suggesting hyperkalemia should be treated as a medical emergency — stop the potassium immediately and seek urgent medical care.

Potassium citrate raises the pH (acidity level) of urine and increases urinary citrate — a compound that binds to calcium and inhibits the formation of kidney stones. The rise in urinary pH also converts uric acid to a more soluble form, reducing uric acid stone formation. These combined effects make the urine a less favorable environment for calcium oxalate, calcium phosphate, and uric acid crystals to develop. With regular dosing, urine citrate rises within the first hour and stays elevated throughout the day, smoothing out the natural fluctuations that would otherwise allow stone-forming conditions to occur.

After a single oral dose of potassium citrate, urinary citrate begins to rise within the first hour and the effect lasts about 12 hours. With continued daily dosing, urinary citrate reaches its peak increase by about the third day of treatment. When treatment is stopped, urinary citrate begins falling back toward pre-treatment levels within the first day. The degree of citrate increase is directly related to the dose prescribed.

Store in a tight container.